Welcome to our dedicated page for Bayfirst Financial SEC filings (Ticker: BAFN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how BayFirst Financial Corp turns hometown deposits into nationwide SBA and residential mortgages is vital, yet its SEC disclosures can exceed 300 pages of banking jargon. Whether you’re hunting for capital-ratio shifts or wondering how gain-on-sale income buffers earnings volatility, digging through each filing is a time-sink investors don’t need.
Stock Titan’s AI engine reads every BayFirst Financial quarterly earnings report 10-Q filing, annual report 10-K, and 8-K material event the minute they appear on EDGAR. We surface plain-English insights, from net interest margin trends to geographic loan-loss data, while linking directly to the source lines for verification. Need BayFirst Financial insider trading Form 4 transactions? Our real-time alerts show exactly when executives buy or sell, so you can spot sentiment shifts before the market reacts.
Use the platform to: compare SBA production figures across quarters, see which board members received new equity grants in the latest proxy statement executive compensation table, and understand BayFirst Financial 8-K material events explained by AI. Historical filing downloads are also preserved, letting professionals back-test trends over multiple years without leaving the page. Every filing type—BayFirst Financial annual report 10-K simplified, Form 4 insider transactions real-time, quarterly earnings report 10-Q updates, and proxy details—is indexed, searchable, and accompanied by concise AI summaries that translate complex regulatory language into actionable context.
Kronos Bio, Inc. (KRON) filed a Form 15-12G with the U.S. SEC on 30 June 2025, certifying the termination of registration of its common stock under Section 12(g) of the Securities Exchange Act of 1934 and suspending the company’s duty to file reports under Sections 13 and 15(d).
The company relied on Rule 12g-4(a)(1) and Rule 12h-3(b)(1)(i), disclosing an approximate holder count of one. No other securities remain subject to reporting obligations. The notice was signed by Chief Financial Officer Michael Hearne.
Once the Form 15 becomes effective, Kronos Bio will no longer submit periodic filings such as Forms 10-K, 10-Q or 8-K, significantly reducing public disclosure and potentially affecting liquidity for remaining shareholders.
FAQ
What is the current stock price of Bayfirst Financial (BAFN)?
What is the market cap of Bayfirst Financial (BAFN)?
What is the primary business model of BayFirst Financial Corp?
How does BayFirst Financial Corp manage its loan portfolio?
Which customer segments does BayFirst primarily serve?
What role do technology platforms play in BayFirst's operations?
How does BayFirst Financial Corp differentiate itself from competitors?
What is the significance of gain-on-sale income for BayFirst?
How does BayFirst ensure financial stability?
What are the key competitive challenges faced by BayFirst Financial Corp?
